Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.92M Sell
67,335
-339
-0.5% -$13.5K 0.01% 816
2026
Q1
$2.68M Buy
67,674
+18,035
+36% +$798K 0.01% 778
2025
Q4
$2.07M Sell
49,639
-5,367
-10% -$221K 0.01% 839
2025
Q3
$2.25M Buy
55,006
+22,555
+70% +$1.01M 0.01% 705
2025
Q2
$1.48M Buy
32,451
+16,869
+108% +$778K 0.01% 797
2025
Q1
$751K Buy
15,582
+711
+5% +$35K 0.01% 941
2024
Q4
$694K Buy
14,871
+3,402
+30% +$178K 0.01% 920
2024
Q3
$650K Buy
11,469
+7,558
+193% +$401K 0.01% 746
2024
Q2
$191K Buy
+3,911
New +$190K 0.01% 856

Other funds holding AMCR

&Partners's AMCR Position: Q2 2026 in Review

&Partners reduced its Amcor (AMCR) stake by 0.5% in Q2 2026, selling an estimated $13.5K and leaving 67,335 shares worth $2.92M. The position accounts for 0.01% of the portfolio, ranked #816.

&Partners first reported a position in AMCR in Q2 2024 and has held it in 9 quarters since. 705 funds tracked by Wall St. Rank hold AMCR as of Q2 2026.

  • &Partners held 67,335 shares of Amcor worth $2.92M as of Q2 2026.
  • &Partners sold 339 Amcor shares in Q2 2026, an estimated $13.5K.
  • Amcor made up 0.01% of &Partners's portfolio in Q2 2026, its #816 holding.
  • &Partners first reported a position in Amcor in Q2 2024 and has held it in 9 quarters since.
  • 705 funds tracked by Wall St. Rank held Amcor as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.